Functional Task Kinematic in Musculoskeletal Pathology.

September 28, 2020 updated by: Dr. Antonio I Cuesta-Vargas, University of Malaga

Functional Task Kinematic in Patient With Musculoskeletal Pathology.

The aim of this project is to create references values to patients with musculoskeletal pathology using functional tasks and measuring with a smartphone and video imaging (3D motion capture cameras).

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Musculoskeletal pathologies can affect bones, muscles, joints and other structures related to this system. These disorders are extremely common and can have an origin from autoimmune, inflammatory, traumatic, etc. The risk of developing this pathologies increases with age.

The diagnosis could delayed by lack of information, expensive assessment or difficult execution.

Currently, you can use a Smartphone to get the same information as sensors. In addition to Smartphone, 3D motion capture systems with a camera have been frequently used to analyse kinematics and are being integrated as a rehabilitation tool in patients. The use of Smartphones and 3D motion capture cameras would help to find fast and cheap assessment methods for professionals.

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Málaga, Spain, 29009
        • Malaga

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients treat in general care or diagnosed by a specialist.

Description

Inclusion Criteria:

  • Persons with diagnosis of musculoskeletal pathology.
  • Age between 20-65 años.
  • Subjects able to get up from the chair at least 5 times.
  • Be able to complete questionnaires and perform functional tasks.

Exclusion Criteria:

  • Subjects who are participating in a study with an experimental treatment.
  • Severe cardiovascular disease.
  • Being pregnant, in case of women.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Acute musculoskeletal pathology patients
Musculoskeletal pathology patients that they will perform functional tasks measuring with motion sensors and motion capture.
The guidelines for the management according to the musculoskeletal disorder in primary care will be the treatment guidelines for the Standard Care.
Match control
Healthy people of the same age as the acute musculoskeletal pathology subjects. They will perform functional tasks measuring with motion sensors and motion capture.
The guidelines for the management according to the musculoskeletal disorder in primary care will be the treatment guidelines for the Standard Care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kinematic analysis by motion sensor
Time Frame: 1 hour
A smartphone will pick up positioning, motion and acceleration information from the subject
1 hour
Kinematic analysis by 3D motion capture
Time Frame: 1 hour
The camera will perform a motion capture of the functional task. This system will calculate the displacement and the time of the functional task
1 hour
Responsiveness
Time Frame: 1 hour
The Responsiveness Box of COSMIN checklist will be used to determinate the response to change of the Smartphone and the 3D cameras. All possible items will be followed.
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life questionnaire: EuroQoL 5D
Time Frame: 1 hour
standardized instrument for use as a measure of health outcome
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Antonio I Cuesta-Vargas, PhD, University of Malaga

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2018

Primary Completion (Actual)

February 1, 2020

Study Completion (Actual)

September 1, 2020

Study Registration Dates

First Submitted

September 21, 2017

First Submitted That Met QC Criteria

September 21, 2017

First Posted (Actual)

September 26, 2017

Study Record Updates

Last Update Posted (Actual)

September 29, 2020

Last Update Submitted That Met QC Criteria

September 28, 2020

Last Verified

July 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • iBAFI01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Disease

Clinical Trials on Standard Care

3
Subscribe